SIBO
11
3
4
4
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
18.2%
2 terminated out of 11 trials
66.7%
-19.9% vs benchmark
0%
0 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (11)
The Safety And Efficacy Of A Probiotic Intervention On Lactulose Hydrogen Breath Test-Positive Patients And Related Gastrointestinal Symptoms
The Role of METhanogens in the PROgression Of Parkinson's Disease and Related Neurological Conditions
Breath Test-Based Assessment of SIBO in Chronic Pancreatitis and Partial Pancreatectomy
The Low FODMAP Diet in Individuals With Small Intestinal Bacterial Overgrowth (SIBO)
Capillary Endoscopy Aspiration Catheter
The Efficacy of Probiotics as an Adjunct to Treatment of SIBO With Rifaximin
Effect of a Low FODMAP Diet on SIBO Breath Test Positivity
Clinical Utility of Handheld Hydrogen Breathalyzer in Identification of Food Sensitivities (AIRE Study)
Efficacy of Rifaximin in Patients With Small Intestinal Bacterial Overgrowth Presenting With Abdominal Bloating.
Systems Biology of Gastrointestinal and Related Diseases
Atrantil for Intestinal Bacterial Overgrowth